Invitrogen’s Sale of BioReliance Topped Most-Read GenomeWeb News Stories Last Week

Feb 19, 2007

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Feb. 16.

1. Invitrogen to Sell BioReliance for $210M; Posts Weak Revenue Gain and $100M Loss in Q4 (from Feb. 14)

2. House Bill Seeks to Prohibit 'All' New Human Genome Patenting (from Feb. 16)

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Now You Can Read Them, Now You Can't

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

The Mouths of Heavy Drinkers Are Disgusting

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

For Health or For Fun?

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

This Week in Genome Research

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.

Main menu